Home>Topics>Companies>Synthes Holding AG

Synthes Holding AG

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. Johnson & Johnson: Valuation Not Attractive Despite Impressive Strategic Alliance

    Headlines

    Fri, 4 Jul 2014

    By Andy Batts : Johnson & Johnson 's ( JNJ ) orthopedics ..... subsidiary DePuy Synthes and Johnson & Johnson Innovation have formed ..... of the implants. Johnson & Johnson Innovation, a newly ..... reputation of DePuy Synthes has been trashed

  2. Tides Turn for These Orthopedic Firms

    Headlines

    Mon, 30 Jun 2014

    competition should help the large, top-tier firms, including Johnson & Johnson JNJ, Zimmer, and Stryker SYK. However, this dynamic will ..... along with the most extensive trauma portfolio thanks to the Synthes acquisition), and then Biomet to make a vocal minority

  3. Medtronic to Buy Covidien, Redomicile in Ireland

    Commentary

    Mon, 16 Jun 2014

    allows it to free up cash trapped overseas. Johnson & Johnson 's acquisition of Synthes in 2011 at 5.4 times sales could be used as ..... prodigious overseas cash balance at that time), but Synthes offered higher operating margins in the mid

  4. New Morningstar Analyst Report for Johnson & Johnson

    Stock Reports

    Tue, 27 May 2014

    of orthopedic device firm Synthes , which was largely driven ..... valuation, as the price paid for Synthes largely accounts for incremental ..... deal. As J&J integrates Synthes , we will be able to gauge ..... to be value-accretive. Johnson & Johnson is the world's largest ..... expect patent losses and the Synthes acquisition to reduce this

  5. New Morningstar Analyst Report for Johnson & Johnson

    Stock Reports

    Tue, 27 May 2014

    for the company. Johnson & Johnson faces relatively few ..... entire spectrum of Johnson & Johnson 's products should ..... s drug division. Johnson & Johnson carries one of the ..... equity portion of the Synthes acquisition, which

  6. Johnson & Johnson Posts Solid 2Q, Buoyed by New Drug Launches and Return of Several OTC Products

    Commentary

    Tue, 16 Jul 2013

    Johnson & Johnson JNJ reported second-quarter results largely in line with our expectations ..... drag on this part of J&J's portfolio. Excluding the acquisition of Synthes and other portfolio changes, J&J's device segment was flat year

  7. J&J Posts Solid 4Q Results, but Offers Weak Outlook for 2013

    Commentary

    Tue, 22 Jan 2013

    inflection point for Johnson & Johnson , and we see the ..... device side, the Synthes acquisition not ..... from the recent Synthes acquisition, Johnson & Johnson posted 4% year ..... period, with the Synthes acquisition providing

  8. J&J Posts 3Q Results Slightly Shy of Our Expectations, but Strong Long-Term Outlook Intact

    Commentary

    Tue, 16 Oct 2012

    Johnson & Johnson JNJ reported third-quarter results slightly below our expectations ..... increased operationally 10.8% year over year as the recently completed Synthes acquisition added 5.8% to growth. This 5% underlying growth represented

« Prev123Next »
Content Partners